×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INAB – in8bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INAB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
04:05 pm
inab
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Low
Report
IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
3/3
09:37 am
inab
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases [Yahoo! Finance]
Medium
Report
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases [Yahoo! Finance]
3/3
09:28 am
inab
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
Medium
Report
IN8bio Announces Advanced Gamma-Delta (?d) T cell Engager (TCE) Platform for Oncology and Autoimmune Diseases
2/26
08:00 am
inab
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
2/24
08:00 am
inab
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Low
Report
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
2/14
11:31 am
inab
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML [Yahoo! Finance]
Medium
Report
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML [Yahoo! Finance]
2/14
09:00 am
inab
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
Medium
Report
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
2/12
08:00 am
inab
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
IN8bio, Inc. (NASDAQ: INAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/13
04:11 pm
inab
Form 10-K IN8BIO, INC. For: Dec 31
Low
Report
Form 10-K IN8BIO, INC. For: Dec 31
3/13
04:08 pm
inab
Form 8-K IN8BIO, INC. For: Mar 13
Low
Report
Form 8-K IN8BIO, INC. For: Mar 13
3/5
04:38 pm
inab
Form PRE 14A IN8BIO, INC. For: May 08
Low
Report
Form PRE 14A IN8BIO, INC. For: May 08
3/5
04:35 pm
inab
Form 8-K IN8BIO, INC. For: Mar 04
Low
Report
Form 8-K IN8BIO, INC. For: Mar 04
3/3
09:29 am
inab
Form 8-K IN8BIO, INC. For: Mar 03
Medium
Report
Form 8-K IN8BIO, INC. For: Mar 03
2/14
04:42 pm
inab
Form SCHEDULE 13G/A IN8BIO, INC. Filed by: Ho William Tai-Wei
Medium
Report
Form SCHEDULE 13G/A IN8BIO, INC. Filed by: Ho William Tai-Wei
2/14
04:30 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: Alyeska Investment Group, L.P.
Medium
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: Alyeska Investment Group, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: